Walleye Trading’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-800
Closed -$97.3K 4718
2025
Q4
$97.3K Sell
800
-7,400
-90% -$929K ﹤0.01% 3750
2025
Q3
$920K Sell
8,200
-1,200
-13% -$140K ﹤0.01% 2332
2025
Q2
$1.26M Buy
9,400
+4,000
+74% +$439K ﹤0.01% 2039
2025
Q1
$363K Sell
5,400
-16,200
-75% -$1.11M ﹤0.01% 2730
2024
Q4
$1.35M Buy
21,600
+18,800
+671% +$1.75M ﹤0.01% 1947
2024
Q3
$440K Buy
2,800
+1,800
+180% +$277K ﹤0.01% 2595
2024
Q2
$151K Sell
1,000
-800
-44% -$96K ﹤0.01% 3218
2024
Q1
$133K Buy
+1,800
New +$148K ﹤0.01% 3650
2023
Q4
Sell
-52,900
Closed -$2.9M 5497
2023
Q3
$2.9M Buy
52,900
+47,500
+880% +$3.42M 0.01% 1499
2023
Q2
$453K Sell
5,400
-3,500
-39% -$268K ﹤0.01% 2828
2023
Q1
$674K Buy
8,900
+4,100
+85% +$284K ﹤0.01% 2547
2022
Q4
$296K Sell
4,800
-11,900
-71% -$633K ﹤0.01% 3252
2022
Q3
$697K Buy
16,700
+4,500
+37% +$196K ﹤0.01% 2600
2022
Q2
$384K Buy
+12,200
New +$325K ﹤0.01% 3153

Other funds holding TMDX

Walleye Trading's TMDX Position: Q1 2026 in Review

Walleye Trading sold out of Transmedics (TMDX) in Q1 2026, closing a stake of 1,200 shares — an estimated $146K sold.

Walleye Trading first reported a position in TMDX in Q2 2021 and held it in 11 quarters. The position peaked at $336K in Q3 2023. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

  • Walleye Trading reported no remaining Transmedics position as of Q1 2026 after selling out during the quarter.
  • Walleye Trading sold 1,200 Transmedics shares in Q1 2026, an estimated $146K.
  • Walleye Trading first reported a position in Transmedics in Q2 2021 and held it in 11 quarters.
  • Walleye Trading's Transmedics position peaked at $336K in Q3 2023.
  • 414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Walleye Trading's 13F filing for Q1 2026, filed 11 May 2026.